Metabolism Drugs Market Forecast to 2027 - Covid-19 Impact and Global Analysis - by Therapy Type (Enzyme Replacement Therapy, Substrate Reduction Therapy, Small Molecule Drugs, Others); Application (Glycogen Metabolism Disease, Lipid Metabolism Disease, Amino Acid Metabolism Disease, Others); Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)
Report Code: TIPRE00004056 No. of Pages: 150 Category: Pharmaceuticals Status: Upcoming
MARKET INTRODUCTION
Metabolism is the process by which the human body converts the food they consume into energy. Metabolism drugs are used to treat metabolic disorders in the human body. Metabolic disorders include glycogen metabolism disease, lipid metabolism disease, amino acid metabolism, metal metabolism disease, etc. Metabolic diseases are can also be genetic. However, metabolic disorders are associated with overweight or obesity and inactivity.
MARKET DYNAMICS
The metabolism drugs market is anticipated to grow in the forecast, owing to the factors such as increasing prevalence of metabolic disease, increasing obesity among the population, technological advancement in the field of drug delivery systems and increasing awareness amongst the patients. However, high cost with research and development of drugs and long duration of treatment hampers the growth of the market.
MARKET SCOPE
The "Global Metabolism Drugs Market Analysis to 2027" is a specialized and in-depth study of the pharmaceuticals industry with a special focus on the global market trend analysis. The report aims to provide an overview of metabolism drugs market with detailed market segmentation by therapy type, application, distribution channel and geography. The global metabolism drugs market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading metabolism drugs market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The global metabolism drugs market is segmented on the basis of therapy type, application, distribution channel and geography. Based on therapy type, the market is segmented as enzyme replacement therapy, substrate reduction therapy, small molecule drugs, others. On the basis of application, the global metabolism drugs market is segmented into glycogen metabolism disease, lipid metabolism disease, amino acid metabolism disease, others. The distribution channel segment is further segmented into hospital pharmacies, retail pharmacies, online pharmacies.REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Metabolism drugs market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Metabolism drugs market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting metabolism drugs market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Metabolism drugs market in these regions.
MARKET PLAYERS
The reports cover key developments in the metabolism drugs market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from Metabolism drugs market are anticipated to lucrative growth opportunities in the future with the rising demand for Metabolism drugs market in the global market. Below mentioned is the list of few companies engaged in the Metabolism drugs market.
The report also includes the profiles of key metabolism drugs market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
Metabolism is the process by which the human body converts the food they consume into energy. Metabolism drugs are used to treat metabolic disorders in the human body. Metabolic disorders include glycogen metabolism disease, lipid metabolism disease, amino acid metabolism, metal metabolism disease, etc. Metabolic diseases are can also be genetic. However, metabolic disorders are associated with overweight or obesity and inactivity.
MARKET DYNAMICS
The metabolism drugs market is anticipated to grow in the forecast, owing to the factors such as increasing prevalence of metabolic disease, increasing obesity among the population, technological advancement in the field of drug delivery systems and increasing awareness amongst the patients. However, high cost with research and development of drugs and long duration of treatment hampers the growth of the market.
MARKET SCOPE
The "Global Metabolism Drugs Market Analysis to 2027" is a specialized and in-depth study of the pharmaceuticals industry with a special focus on the global market trend analysis. The report aims to provide an overview of metabolism drugs market with detailed market segmentation by therapy type, application, distribution channel and geography. The global metabolism drugs market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading metabolism drugs market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The global metabolism drugs market is segmented on the basis of therapy type, application, distribution channel and geography. Based on therapy type, the market is segmented as enzyme replacement therapy, substrate reduction therapy, small molecule drugs, others. On the basis of application, the global metabolism drugs market is segmented into glycogen metabolism disease, lipid metabolism disease, amino acid metabolism disease, others. The distribution channel segment is further segmented into hospital pharmacies, retail pharmacies, online pharmacies.REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Metabolism drugs market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Metabolism drugs market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting metabolism drugs market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Metabolism drugs market in these regions.
MARKET PLAYERS
The reports cover key developments in the metabolism drugs market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from Metabolism drugs market are anticipated to lucrative growth opportunities in the future with the rising demand for Metabolism drugs market in the global market. Below mentioned is the list of few companies engaged in the Metabolism drugs market.
The report also includes the profiles of key metabolism drugs market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Merck & Co., Inc.
- Novartis AG
- Amicus Therapeutics
- AstraZeneca Plc
- Boehringer Ingelheim
- Shire Plc
- Sanofi Genzyme
- BioMarin Pharmaceutical, Inc.
- Horizon Pharma Plc
- GlaxoSmithKline Plc.
TABLE OF CONTENTS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Metabolism Drugs Market - By Therapy Type
1.3.2 Metabolism Drugs Market - By Application
1.3.3 Metabolism Drugs Market - By Distribution Channel
1.3.4 Metabolism Drugs Market - By Region
1.3.4.1 By Country
2. KEY TAKEWAYS
3. RESEARCH METHODOLOGY
4. METABOLISM DRUGS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. METABOLISM DRUGS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. METABOLISM DRUGS MARKET - GLOBAL MARKET ANALYSIS
6.1. METABOLISM DRUGS - GLOBAL MARKET OVERVIEW
6.2. METABOLISM DRUGS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. METABOLISM DRUGS MARKET - REVENUE AND FORECASTS TO 2027 - THERAPY TYPE
7.1. OVERVIEW
7.2. THERAPY TYPE MARKET FORECASTS AND ANALYSIS
7.3. ENZYME REPLACEMENT THERAPY
7.3.1. Overview
7.3.2. Enzyme Replacement Therapy Market Forecast and Analysis
7.4. SUBSTRATE REDUCTION THERAPY
7.4.1. Overview
7.4.2. Substrate Reduction Therapy Market Forecast and Analysis
7.5. SMALL MOLECULE DRUGS
7.5.1. Overview
7.5.2. Small Molecule Drugs Market Forecast and Analysis
7.6. OTHERS
7.6.1. Overview
7.6.2. Others Market Forecast and Analysis
8. METABOLISM DRUGS MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. GLYCOGEN METABOLISM DISEASE
8.3.1. Overview
8.3.2. Glycogen Metabolism Disease Market Forecast and Analysis
8.4. LIPID METABOLISM DISEASE
8.4.1. Overview
8.4.2. Lipid Metabolism Disease Market Forecast and Analysis
8.5. AMINO ACID METABOLISM DISEASE
8.5.1. Overview
8.5.2. Amino Acid Metabolism Disease Market Forecast and Analysis
8.6. OTHERS
8.6.1. Overview
8.6.2. Others Market Forecast and Analysis
9. METABOLISM DRUGS MARKET - REVENUE AND FORECASTS TO 2027 - DISTRIBUTION CHANNEL
9.1. OVERVIEW
9.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
9.3. HOSPITAL PHARMACIES
9.3.1. Overview
9.3.2. Hospital Pharmacies Market Forecast and Analysis
9.4. RETAIL PHARMACIES
9.4.1. Overview
9.4.2. Retail Pharmacies Market Forecast and Analysis
9.5. ONLINE PHARMACIES
9.5.1. Overview
9.5.2. Online Pharmacies Market Forecast and Analysis
10. METABOLISM DRUGS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Metabolism Drugs Market Overview
10.1.2 North America Metabolism Drugs Market Forecasts and Analysis
10.1.3 North America Metabolism Drugs Market Forecasts and Analysis - By Therapy Type
10.1.4 North America Metabolism Drugs Market Forecasts and Analysis - By Application
10.1.5 North America Metabolism Drugs Market Forecasts and Analysis - By Distribution Channel
10.1.6 North America Metabolism Drugs Market Forecasts and Analysis - By Countries
10.1.6.1 United States Metabolism Drugs Market
10.1.6.1.1 United States Metabolism Drugs Market by Therapy Type
10.1.6.1.2 United States Metabolism Drugs Market by Application
10.1.6.1.3 United States Metabolism Drugs Market by Distribution Channel
10.1.6.2 Canada Metabolism Drugs Market
10.1.6.2.1 Canada Metabolism Drugs Market by Therapy Type
10.1.6.2.2 Canada Metabolism Drugs Market by Application
10.1.6.2.3 Canada Metabolism Drugs Market by Distribution Channel
10.1.6.3 Mexico Metabolism Drugs Market
10.1.6.3.1 Mexico Metabolism Drugs Market by Therapy Type
10.1.6.3.2 Mexico Metabolism Drugs Market by Application
10.1.6.3.3 Mexico Metabolism Drugs Market by Distribution Channel
10.2. EUROPE
10.2.1 Europe Metabolism Drugs Market Overview
10.2.2 Europe Metabolism Drugs Market Forecasts and Analysis
10.2.3 Europe Metabolism Drugs Market Forecasts and Analysis - By Therapy Type
10.2.4 Europe Metabolism Drugs Market Forecasts and Analysis - By Application
10.2.5 Europe Metabolism Drugs Market Forecasts and Analysis - By Distribution Channel
10.2.6 Europe Metabolism Drugs Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Metabolism Drugs Market
10.2.6.1.1 Germany Metabolism Drugs Market by Therapy Type
10.2.6.1.2 Germany Metabolism Drugs Market by Application
10.2.6.1.3 Germany Metabolism Drugs Market by Distribution Channel
10.2.6.2 France Metabolism Drugs Market
10.2.6.2.1 France Metabolism Drugs Market by Therapy Type
10.2.6.2.2 France Metabolism Drugs Market by Application
10.2.6.2.3 France Metabolism Drugs Market by Distribution Channel
10.2.6.3 Italy Metabolism Drugs Market
10.2.6.3.1 Italy Metabolism Drugs Market by Therapy Type
10.2.6.3.2 Italy Metabolism Drugs Market by Application
10.2.6.3.3 Italy Metabolism Drugs Market by Distribution Channel
10.2.6.4 Spain Metabolism Drugs Market
10.2.6.4.1 Spain Metabolism Drugs Market by Therapy Type
10.2.6.4.2 Spain Metabolism Drugs Market by Application
10.2.6.4.3 Spain Metabolism Drugs Market by Distribution Channel
10.2.6.5 United Kingdom Metabolism Drugs Market
10.2.6.5.1 United Kingdom Metabolism Drugs Market by Therapy Type
10.2.6.5.2 United Kingdom Metabolism Drugs Market by Application
10.2.6.5.3 United Kingdom Metabolism Drugs Market by Distribution Channel
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Metabolism Drugs Market Overview
10.3.2 Asia-Pacific Metabolism Drugs Market Forecasts and Analysis
10.3.3 Asia-Pacific Metabolism Drugs Market Forecasts and Analysis - By Therapy Type
10.3.4 Asia-Pacific Metabolism Drugs Market Forecasts and Analysis - By Application
10.3.5 Asia-Pacific Metabolism Drugs Market Forecasts and Analysis - By Distribution Channel
10.3.6 Asia-Pacific Metabolism Drugs Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Metabolism Drugs Market
10.3.6.1.1 Australia Metabolism Drugs Market by Therapy Type
10.3.6.1.2 Australia Metabolism Drugs Market by Application
10.3.6.1.3 Australia Metabolism Drugs Market by Distribution Channel
10.3.6.2 China Metabolism Drugs Market
10.3.6.2.1 China Metabolism Drugs Market by Therapy Type
10.3.6.2.2 China Metabolism Drugs Market by Application
10.3.6.2.3 China Metabolism Drugs Market by Distribution Channel
10.3.6.3 India Metabolism Drugs Market
10.3.6.3.1 India Metabolism Drugs Market by Therapy Type
10.3.6.3.2 India Metabolism Drugs Market by Application
10.3.6.3.3 India Metabolism Drugs Market by Distribution Channel
10.3.6.4 Japan Metabolism Drugs Market
10.3.6.4.1 Japan Metabolism Drugs Market by Therapy Type
10.3.6.4.2 Japan Metabolism Drugs Market by Application
10.3.6.4.3 Japan Metabolism Drugs Market by Distribution Channel
10.3.6.5 South Korea Metabolism Drugs Market
10.3.6.5.1 South Korea Metabolism Drugs Market by Therapy Type
10.3.6.5.2 South Korea Metabolism Drugs Market by Application
10.3.6.5.3 South Korea Metabolism Drugs Market by Distribution Channel
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Metabolism Drugs Market Overview
10.4.2 Middle East and Africa Metabolism Drugs Market Forecasts and Analysis
10.4.3 Middle East and Africa Metabolism Drugs Market Forecasts and Analysis - By Therapy Type
10.4.4 Middle East and Africa Metabolism Drugs Market Forecasts and Analysis - By Application
10.4.5 Middle East and Africa Metabolism Drugs Market Forecasts and Analysis - By Distribution Channel
10.4.6 Middle East and Africa Metabolism Drugs Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Metabolism Drugs Market
10.4.6.1.1 South Africa Metabolism Drugs Market by Therapy Type
10.4.6.1.2 South Africa Metabolism Drugs Market by Application
10.4.6.1.3 South Africa Metabolism Drugs Market by Distribution Channel
10.4.6.2 Saudi Arabia Metabolism Drugs Market
10.4.6.2.1 Saudi Arabia Metabolism Drugs Market by Therapy Type
10.4.6.2.2 Saudi Arabia Metabolism Drugs Market by Application
10.4.6.2.3 Saudi Arabia Metabolism Drugs Market by Distribution Channel
10.4.6.3 U.A.E Metabolism Drugs Market
10.4.6.3.1 U.A.E Metabolism Drugs Market by Therapy Type
10.4.6.3.2 U.A.E Metabolism Drugs Market by Application
10.4.6.3.3 U.A.E Metabolism Drugs Market by Distribution Channel
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Metabolism Drugs Market Overview
10.5.2 South and Central America Metabolism Drugs Market Forecasts and Analysis
10.5.3 South and Central America Metabolism Drugs Market Forecasts and Analysis - By Therapy Type
10.5.4 South and Central America Metabolism Drugs Market Forecasts and Analysis - By Application
10.5.5 South and Central America Metabolism Drugs Market Forecasts and Analysis - By Distribution Channel
10.5.6 South and Central America Metabolism Drugs Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Metabolism Drugs Market
10.5.6.1.1 Brazil Metabolism Drugs Market by Therapy Type
10.5.6.1.2 Brazil Metabolism Drugs Market by Application
10.5.6.1.3 Brazil Metabolism Drugs Market by Distribution Channel
10.5.6.2 Argentina Metabolism Drugs Market
10.5.6.2.1 Argentina Metabolism Drugs Market by Therapy Type
10.5.6.2.2 Argentina Metabolism Drugs Market by Application
10.5.6.2.3 Argentina Metabolism Drugs Market by Distribution Channel
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. METABOLISM DRUGS MARKET, KEY COMPANY PROFILES
12.1. MERCK AND CO., INC.
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. NOVARTIS AG
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. AMICUS THERAPEUTICS
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. ASTRAZENECA PLC
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. BOEHRINGER INGELHEIM
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. SHIRE PLC
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. SANOFI GENZYME
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. GLAXOSMITHKLINE PLC
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. HORIZON PHARMA PLC
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. BIOMARIN PHARMACEUTICAL, INC.
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Metabolism Drugs Market - By Therapy Type
1.3.2 Metabolism Drugs Market - By Application
1.3.3 Metabolism Drugs Market - By Distribution Channel
1.3.4 Metabolism Drugs Market - By Region
1.3.4.1 By Country
2. KEY TAKEWAYS
3. RESEARCH METHODOLOGY
4. METABOLISM DRUGS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. METABOLISM DRUGS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. METABOLISM DRUGS MARKET - GLOBAL MARKET ANALYSIS
6.1. METABOLISM DRUGS - GLOBAL MARKET OVERVIEW
6.2. METABOLISM DRUGS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. METABOLISM DRUGS MARKET - REVENUE AND FORECASTS TO 2027 - THERAPY TYPE
7.1. OVERVIEW
7.2. THERAPY TYPE MARKET FORECASTS AND ANALYSIS
7.3. ENZYME REPLACEMENT THERAPY
7.3.1. Overview
7.3.2. Enzyme Replacement Therapy Market Forecast and Analysis
7.4. SUBSTRATE REDUCTION THERAPY
7.4.1. Overview
7.4.2. Substrate Reduction Therapy Market Forecast and Analysis
7.5. SMALL MOLECULE DRUGS
7.5.1. Overview
7.5.2. Small Molecule Drugs Market Forecast and Analysis
7.6. OTHERS
7.6.1. Overview
7.6.2. Others Market Forecast and Analysis
8. METABOLISM DRUGS MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. GLYCOGEN METABOLISM DISEASE
8.3.1. Overview
8.3.2. Glycogen Metabolism Disease Market Forecast and Analysis
8.4. LIPID METABOLISM DISEASE
8.4.1. Overview
8.4.2. Lipid Metabolism Disease Market Forecast and Analysis
8.5. AMINO ACID METABOLISM DISEASE
8.5.1. Overview
8.5.2. Amino Acid Metabolism Disease Market Forecast and Analysis
8.6. OTHERS
8.6.1. Overview
8.6.2. Others Market Forecast and Analysis
9. METABOLISM DRUGS MARKET - REVENUE AND FORECASTS TO 2027 - DISTRIBUTION CHANNEL
9.1. OVERVIEW
9.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
9.3. HOSPITAL PHARMACIES
9.3.1. Overview
9.3.2. Hospital Pharmacies Market Forecast and Analysis
9.4. RETAIL PHARMACIES
9.4.1. Overview
9.4.2. Retail Pharmacies Market Forecast and Analysis
9.5. ONLINE PHARMACIES
9.5.1. Overview
9.5.2. Online Pharmacies Market Forecast and Analysis
10. METABOLISM DRUGS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Metabolism Drugs Market Overview
10.1.2 North America Metabolism Drugs Market Forecasts and Analysis
10.1.3 North America Metabolism Drugs Market Forecasts and Analysis - By Therapy Type
10.1.4 North America Metabolism Drugs Market Forecasts and Analysis - By Application
10.1.5 North America Metabolism Drugs Market Forecasts and Analysis - By Distribution Channel
10.1.6 North America Metabolism Drugs Market Forecasts and Analysis - By Countries
10.1.6.1 United States Metabolism Drugs Market
10.1.6.1.1 United States Metabolism Drugs Market by Therapy Type
10.1.6.1.2 United States Metabolism Drugs Market by Application
10.1.6.1.3 United States Metabolism Drugs Market by Distribution Channel
10.1.6.2 Canada Metabolism Drugs Market
10.1.6.2.1 Canada Metabolism Drugs Market by Therapy Type
10.1.6.2.2 Canada Metabolism Drugs Market by Application
10.1.6.2.3 Canada Metabolism Drugs Market by Distribution Channel
10.1.6.3 Mexico Metabolism Drugs Market
10.1.6.3.1 Mexico Metabolism Drugs Market by Therapy Type
10.1.6.3.2 Mexico Metabolism Drugs Market by Application
10.1.6.3.3 Mexico Metabolism Drugs Market by Distribution Channel
10.2. EUROPE
10.2.1 Europe Metabolism Drugs Market Overview
10.2.2 Europe Metabolism Drugs Market Forecasts and Analysis
10.2.3 Europe Metabolism Drugs Market Forecasts and Analysis - By Therapy Type
10.2.4 Europe Metabolism Drugs Market Forecasts and Analysis - By Application
10.2.5 Europe Metabolism Drugs Market Forecasts and Analysis - By Distribution Channel
10.2.6 Europe Metabolism Drugs Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Metabolism Drugs Market
10.2.6.1.1 Germany Metabolism Drugs Market by Therapy Type
10.2.6.1.2 Germany Metabolism Drugs Market by Application
10.2.6.1.3 Germany Metabolism Drugs Market by Distribution Channel
10.2.6.2 France Metabolism Drugs Market
10.2.6.2.1 France Metabolism Drugs Market by Therapy Type
10.2.6.2.2 France Metabolism Drugs Market by Application
10.2.6.2.3 France Metabolism Drugs Market by Distribution Channel
10.2.6.3 Italy Metabolism Drugs Market
10.2.6.3.1 Italy Metabolism Drugs Market by Therapy Type
10.2.6.3.2 Italy Metabolism Drugs Market by Application
10.2.6.3.3 Italy Metabolism Drugs Market by Distribution Channel
10.2.6.4 Spain Metabolism Drugs Market
10.2.6.4.1 Spain Metabolism Drugs Market by Therapy Type
10.2.6.4.2 Spain Metabolism Drugs Market by Application
10.2.6.4.3 Spain Metabolism Drugs Market by Distribution Channel
10.2.6.5 United Kingdom Metabolism Drugs Market
10.2.6.5.1 United Kingdom Metabolism Drugs Market by Therapy Type
10.2.6.5.2 United Kingdom Metabolism Drugs Market by Application
10.2.6.5.3 United Kingdom Metabolism Drugs Market by Distribution Channel
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Metabolism Drugs Market Overview
10.3.2 Asia-Pacific Metabolism Drugs Market Forecasts and Analysis
10.3.3 Asia-Pacific Metabolism Drugs Market Forecasts and Analysis - By Therapy Type
10.3.4 Asia-Pacific Metabolism Drugs Market Forecasts and Analysis - By Application
10.3.5 Asia-Pacific Metabolism Drugs Market Forecasts and Analysis - By Distribution Channel
10.3.6 Asia-Pacific Metabolism Drugs Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Metabolism Drugs Market
10.3.6.1.1 Australia Metabolism Drugs Market by Therapy Type
10.3.6.1.2 Australia Metabolism Drugs Market by Application
10.3.6.1.3 Australia Metabolism Drugs Market by Distribution Channel
10.3.6.2 China Metabolism Drugs Market
10.3.6.2.1 China Metabolism Drugs Market by Therapy Type
10.3.6.2.2 China Metabolism Drugs Market by Application
10.3.6.2.3 China Metabolism Drugs Market by Distribution Channel
10.3.6.3 India Metabolism Drugs Market
10.3.6.3.1 India Metabolism Drugs Market by Therapy Type
10.3.6.3.2 India Metabolism Drugs Market by Application
10.3.6.3.3 India Metabolism Drugs Market by Distribution Channel
10.3.6.4 Japan Metabolism Drugs Market
10.3.6.4.1 Japan Metabolism Drugs Market by Therapy Type
10.3.6.4.2 Japan Metabolism Drugs Market by Application
10.3.6.4.3 Japan Metabolism Drugs Market by Distribution Channel
10.3.6.5 South Korea Metabolism Drugs Market
10.3.6.5.1 South Korea Metabolism Drugs Market by Therapy Type
10.3.6.5.2 South Korea Metabolism Drugs Market by Application
10.3.6.5.3 South Korea Metabolism Drugs Market by Distribution Channel
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Metabolism Drugs Market Overview
10.4.2 Middle East and Africa Metabolism Drugs Market Forecasts and Analysis
10.4.3 Middle East and Africa Metabolism Drugs Market Forecasts and Analysis - By Therapy Type
10.4.4 Middle East and Africa Metabolism Drugs Market Forecasts and Analysis - By Application
10.4.5 Middle East and Africa Metabolism Drugs Market Forecasts and Analysis - By Distribution Channel
10.4.6 Middle East and Africa Metabolism Drugs Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Metabolism Drugs Market
10.4.6.1.1 South Africa Metabolism Drugs Market by Therapy Type
10.4.6.1.2 South Africa Metabolism Drugs Market by Application
10.4.6.1.3 South Africa Metabolism Drugs Market by Distribution Channel
10.4.6.2 Saudi Arabia Metabolism Drugs Market
10.4.6.2.1 Saudi Arabia Metabolism Drugs Market by Therapy Type
10.4.6.2.2 Saudi Arabia Metabolism Drugs Market by Application
10.4.6.2.3 Saudi Arabia Metabolism Drugs Market by Distribution Channel
10.4.6.3 U.A.E Metabolism Drugs Market
10.4.6.3.1 U.A.E Metabolism Drugs Market by Therapy Type
10.4.6.3.2 U.A.E Metabolism Drugs Market by Application
10.4.6.3.3 U.A.E Metabolism Drugs Market by Distribution Channel
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Metabolism Drugs Market Overview
10.5.2 South and Central America Metabolism Drugs Market Forecasts and Analysis
10.5.3 South and Central America Metabolism Drugs Market Forecasts and Analysis - By Therapy Type
10.5.4 South and Central America Metabolism Drugs Market Forecasts and Analysis - By Application
10.5.5 South and Central America Metabolism Drugs Market Forecasts and Analysis - By Distribution Channel
10.5.6 South and Central America Metabolism Drugs Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Metabolism Drugs Market
10.5.6.1.1 Brazil Metabolism Drugs Market by Therapy Type
10.5.6.1.2 Brazil Metabolism Drugs Market by Application
10.5.6.1.3 Brazil Metabolism Drugs Market by Distribution Channel
10.5.6.2 Argentina Metabolism Drugs Market
10.5.6.2.1 Argentina Metabolism Drugs Market by Therapy Type
10.5.6.2.2 Argentina Metabolism Drugs Market by Application
10.5.6.2.3 Argentina Metabolism Drugs Market by Distribution Channel
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. METABOLISM DRUGS MARKET, KEY COMPANY PROFILES
12.1. MERCK AND CO., INC.
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. NOVARTIS AG
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. AMICUS THERAPEUTICS
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. ASTRAZENECA PLC
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. BOEHRINGER INGELHEIM
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. SHIRE PLC
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. SANOFI GENZYME
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. GLAXOSMITHKLINE PLC
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. HORIZON PHARMA PLC
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. BIOMARIN PHARMACEUTICAL, INC.
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies
1. Merck & Co., Inc.
2. Novartis AG
3. Amicus Therapeutics
4. AstraZeneca Plc
5. Boehringer Ingelheim
6. Shire Plc
7. Sanofi Genzyme
8. BioMarin Pharmaceutical, Inc.
9. Horizon Pharma Plc
10. GlaxoSmithKline Plc.
1. Merck & Co., Inc.
2. Novartis AG
3. Amicus Therapeutics
4. AstraZeneca Plc
5. Boehringer Ingelheim
6. Shire Plc
7. Sanofi Genzyme
8. BioMarin Pharmaceutical, Inc.
9. Horizon Pharma Plc
10. GlaxoSmithKline Plc.